Cancer drug
Astellas and Hoyng ROKH successfully defend Xtandi in the Netherlands
Generic drug companies cannot launch their enzalutamide products in the Netherlands. In the pan-European dispute over prostate cancer drug Xtandi, the
...
20 June 2025 by Konstanze Richter